Nanocell targeting using engineered bispecific antibodies

There are many design formats for bispecific antibodies (BsAbs), and the best design choice is highly dependent on the final application. Our aim was to engineer BsAbs to target a novel nanocell (EnGeneIC Delivery Vehicle or EDV(TM)nanocell) to the epidermal growth factor receptor (EGFR). EDV(TM)nan...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Karin, Howard, Christopher B, Jones, Martina L, Sedliarou, Ilya, MacDiarmid, Jennifer, Brahmbhatt, Himanshu, Munro, Trent P, Mahler, Stephen M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622061/
https://www.ncbi.nlm.nih.gov/pubmed/25523746
http://dx.doi.org/10.4161/19420862.2014.985952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622061/
https://www.ncbi.nlm.nih.gov/pubmed/25523746
http://dx.doi.org/10.4161/19420862.2014.985952

Ejemplares similares